Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CR8F | ISIN: US47103J1051 | Ticker-Symbol:
NASDAQ
27.06.25 | 21:59
23,180 US-Dollar
-1,45 % -0,340
1-Jahres-Chart
JANUX THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
JANUX THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur JANUX THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.06.Janux Therapeutics berichtet über Ergebnisse der Jahreshauptversammlung-
13.06.Janux Therapeutics, Inc. - 8-K, Current Report2
12.05.Leerink cuts Janux Therapeutics price target to $89, keeps Outperform2
JANUX THERAPEUTICS Aktie jetzt für 0€ handeln
09.05.Janux Therapeutics GAAP EPS of -$0.381
08.05.Janux Therapeutics, Inc. - 10-Q, Quarterly Report2
08.05.Janux Therapeutics, Inc. - 8-K, Current Report1
05.05.Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross' Stock Picks with Huge Upside Potential1
05.05.Janux Therapeutics begins phase 1b trial for prostate cancer therapy1
06.03.Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently1
28.02.Cantor Fitzgerald maintains $200 target on Janux Therapeutics stock4
27.02.Janux Therapeutics GAAP EPS of -$0.36 beats by $0.071
27.02.Janux Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
27.02.Janux Therapeutics, Inc. - 10-K, Annual Report-
27.02.Janux Therapeutics, Inc. - 8-K, Current Report-
24.02.Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now1
03.12.24Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences1.089CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up...
► Artikel lesen
02.12.24Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC224SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
06.11.24Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights242SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
07.08.24Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights324SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1